John R. Stuelpnagel, Director at 10x Genomics, Inc. (TXG), sold 10,000 shares at $150.56 ($1.5M) on 2021-12-30, disclosed to the SEC on 2022-01-04.
Open-market sale of $1.5M TXG by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.56 | 3,218 | $485K | 32.1% |
| 2 | $150.56 | 3,218 | $485K | 32.1% |
| 3 | $151.57 | 1,782 | $270K | 17.9% |
| 4 | $151.57 | 1,782 | $270K | 17.9% |
| Total | $150.92 avg | 10,000 | $1.5M | 100% |
| Filing → |
| TXG | SELL | 2023-06-07 | $549K | — | Filing → |
| TXG | SELL | 2021-12-03 | $756K | — | Filing → |
| TXG | SELL | 2021-11-18 | $1.6M | — | Filing → |